Mesothelioma cancer is an aggressive type of rare cancer that develops in cells that begin to grow out of control in the mesothelium, which is the lining that surrounds many of the body’s internal organs. Approximately 3,000 cases are diagnosed each year in the U.S. and is also more commonly found in older adults as the average age of persons diagnosed with mesothelioma is 64+
There are 3 common forms of mesothelioma :
1. Pleural Mesothelioma - Lungs
2. Peritoneal Mesothelioma - Intestines
3. Pericardial Mesothelioma - Heart
Very rarely mesothelioma will appear in the lining that surrounds the testis. This is called tunica vaginalis.
Asbestos and mesothelioma are infamously related. Mesothelioma is a form of cancer that affects people who have been exposed to asbestos. It is a rare form of cancer, and affects only those people who have had a history of exposure to asbestos, not others. However, there can be secondary cases, where a person may come into contact with someone who has been exposed to asbestos in the past. The key to mesothelioma, as is apparent here, is exposure to asbestos.
Mesothelioma Cancer Guide
Though asbestos was thought to be useful for its flame-resistance properties,long-term exposure to its particles and fine fibres has been prove to pose serious health risks to people who come into prolonged contact with it.Due to its widespread use all over the world,hundreds of millions are exposed to asbestos,even to this day.Unfortunately,prolonged exposure can lead to mesothelioma cancer,a debilitating disease in which there is no cure.
Mesothelioma cancer is a cancer of thin lining surrounding the lungs, otherwise known aspleural mesothelioma.Asbestos fibers can also attack the lining of the abdominal cavity,resulting in peritoneal mesothelioma.Additionally,the diseases sometimes affects the sac which surrounds the heart, as well as other organs in the body.
Realistic survival rate for cancer (all cancer types) in 2020 & 2030?
By 2020, we may have found substantial evidence for a specific cancer cure.
-2021: Additional Research
-2022: Investigating its applications in Vivo (mice and mammalian).
-2023: Publications and review stating potential solutions and improvements.
-2024: Test a large diversity of populous animals and check vitals.
-2025: Pathology and microscopy.
-2026: Testing different cancer models.
-2027: Compare this treatment to past therapy.
-2028: Undergo review from National Health Institute (NIH)
-2029: Receive or do not Receives funds from NIH (if no funds are available research practically stops, unless there is a new proposal).
After this time period, we’ve achieved additional investigating, but there are no clinical trials.
By 2030: If this is accepted and has substantial data with MANY variables, than cancer rates could decrease ~40–68%
-2030: If accepted from NIH and national boards for review, clinical trials may begin.
-2031: Receive clinical trials, compile data, and publish with the consent of the patient.
-2032: If clinical trials are successful, there is now a new release of therapy.
As you can see, this is an extremely laborious and meticulous process. We are putting many patients lives at risk. Below is my personal opinion on what might happen.
Depending on the amount of biomedical development we experience in these years, there could be a drastic change towards oncotherapy and cancer therapeutics. The current treatment plans are ineffective and target imprecise areas. However, if we find alternative clinical models which fix DNA mutations with Genome engineering, cancer survival rates could increase.
There is no precise anticipation, but we do have an approximation. In my laboratory department, there are incredible discoveries in virotherapy, STEM cell therapy, etc. The exploration into cancer is expanding. Personally, the most hopeful method of future cancer treatment and diagnosis is genome engineering. There is substantial evidence that cancer is caused by mutation from both innate (born) and external changes. If genetic editing could readjust a DNA mutation, this could have importance.
My lab is investigating the significance of tumor suppressor genes. Tumor suppressor genes can regulate cell replication and its mechanisms. During cancer, common tumor suppressors are disabled, which causes uncontrollable cell increases. By using genome engineering, we can reinsert a critical gene. By 2020, we might find one potential solution which needs ADDITIONAL consideration. Due to medical policies, unless it’s a pandemic, vaccination/medications need to undergo deep analysis. By 2030: I don’t want to be audacious, but there could be a cure to a specific cancer.
There are 3 common forms of mesothelioma :
1. Pleural Mesothelioma - Lungs
2. Peritoneal Mesothelioma - Intestines
3. Pericardial Mesothelioma - Heart
Very rarely mesothelioma will appear in the lining that surrounds the testis. This is called tunica vaginalis.
Asbestos and mesothelioma are infamously related. Mesothelioma is a form of cancer that affects people who have been exposed to asbestos. It is a rare form of cancer, and affects only those people who have had a history of exposure to asbestos, not others. However, there can be secondary cases, where a person may come into contact with someone who has been exposed to asbestos in the past. The key to mesothelioma, as is apparent here, is exposure to asbestos.
Mesothelioma Cancer Guide
Though asbestos was thought to be useful for its flame-resistance properties,long-term exposure to its particles and fine fibres has been prove to pose serious health risks to people who come into prolonged contact with it.Due to its widespread use all over the world,hundreds of millions are exposed to asbestos,even to this day.Unfortunately,prolonged exposure can lead to mesothelioma cancer,a debilitating disease in which there is no cure.
Mesothelioma cancer is a cancer of thin lining surrounding the lungs, otherwise known aspleural mesothelioma.Asbestos fibers can also attack the lining of the abdominal cavity,resulting in peritoneal mesothelioma.Additionally,the diseases sometimes affects the sac which surrounds the heart, as well as other organs in the body.
Realistic survival rate for cancer (all cancer types) in 2020 & 2030?
By 2020, we may have found substantial evidence for a specific cancer cure.
-2021: Additional Research
-2022: Investigating its applications in Vivo (mice and mammalian).
-2023: Publications and review stating potential solutions and improvements.
-2024: Test a large diversity of populous animals and check vitals.
-2025: Pathology and microscopy.
-2026: Testing different cancer models.
-2027: Compare this treatment to past therapy.
-2028: Undergo review from National Health Institute (NIH)
-2029: Receive or do not Receives funds from NIH (if no funds are available research practically stops, unless there is a new proposal).
After this time period, we’ve achieved additional investigating, but there are no clinical trials.
By 2030: If this is accepted and has substantial data with MANY variables, than cancer rates could decrease ~40–68%
-2030: If accepted from NIH and national boards for review, clinical trials may begin.
-2031: Receive clinical trials, compile data, and publish with the consent of the patient.
-2032: If clinical trials are successful, there is now a new release of therapy.
As you can see, this is an extremely laborious and meticulous process. We are putting many patients lives at risk. Below is my personal opinion on what might happen.
Depending on the amount of biomedical development we experience in these years, there could be a drastic change towards oncotherapy and cancer therapeutics. The current treatment plans are ineffective and target imprecise areas. However, if we find alternative clinical models which fix DNA mutations with Genome engineering, cancer survival rates could increase.
There is no precise anticipation, but we do have an approximation. In my laboratory department, there are incredible discoveries in virotherapy, STEM cell therapy, etc. The exploration into cancer is expanding. Personally, the most hopeful method of future cancer treatment and diagnosis is genome engineering. There is substantial evidence that cancer is caused by mutation from both innate (born) and external changes. If genetic editing could readjust a DNA mutation, this could have importance.
My lab is investigating the significance of tumor suppressor genes. Tumor suppressor genes can regulate cell replication and its mechanisms. During cancer, common tumor suppressors are disabled, which causes uncontrollable cell increases. By using genome engineering, we can reinsert a critical gene. By 2020, we might find one potential solution which needs ADDITIONAL consideration. Due to medical policies, unless it’s a pandemic, vaccination/medications need to undergo deep analysis. By 2030: I don’t want to be audacious, but there could be a cure to a specific cancer.
No comments:
Post a Comment